Skip to content
Screener

Biohaven BHVN Q4 2025 Annual earnings

Reported March 2, 2026 · After market close

EPS-$1.21Beat by $0.01
Revenue estimate$400.0K
EPS estimate-$1.22

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$70.0M
EPS estimate-$0.61

Financials

Q4 2025

Income statement

See full
Operating income-$142.7M+24.8%
Net income-$145.6M+22.1%
EPS (diluted)-$1.12+37.1%

Balance sheet

See full
Cash & equivalents$232.8M+127%
Total debt$284.6M+678%
Total equity$52.1M-87.7%
Total assets$451.4M-26.6%

Cash flow

See full
Operating cash flow-$130.7M+23.5%
CapEx$8.0K-83.7%
Free cash flow-$130.7M+23.5%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$1.5B-60.3%
Enterprise value$1.55B-58.2%

Returns & leverage

See full
Return on equity-310.8%+400pp
Debt / equity5.5×+5.4×
Current ratio3.2×-0.3×

FAQ

When did Biohaven report Q4 2025 earnings?
Biohaven (BHVN) reported Q4 2025 earnings on March 2, 2026 after market close.
What were Biohaven's Q4 2025 revenue and EPS?
Biohaven reported eps of $-1.21 for Q4 2025.
Did Biohaven beat estimates in Q4 2025?
EPS beat the consensus estimate of $-1.22 by $0.01.
How did Biohaven's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 34.6% from $-1.85.
Where can I find Biohaven's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001935979-26-000022) and the 10-K periodic report (0001935979-26-000020) directly on SEC EDGAR. The filing index links above go to sec.gov.